Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines

作者: M. Neale Weitzmann , Simone Cenci , Leonard Rifas , Christopher Brown , Roberto Pacifici

DOI: 10.1182/BLOOD.V96.5.1873.H8001873_1873_1878

关键词: OsteoprotegerinCytokineStromal cellMacrophage colony-stimulating factorEndocrinologyRANKLMedicineTumor necrosis factor alphaCell biologyInternal medicineOsteoclastT cell

摘要: In unstimulated conditions osteoclast renewal occurs as a result of the stromal cell production key osteoclastogenic factors, receptor activator NFkB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). Inflammation is known to cause increased osteoclastogenesis; however, mechanisms responsible for this phenomenon are poorly understood. We now show that interleukin-1 (IL-1) tumor necrosis alpha (TNFalpha), cytokines typically produced in inflammatory conditions, increase IL-7. This factor, turn, up-regulates by T cells leading stimulation (OC) formation. Although were found produce soluble forms both RANKL M-CSF, saturating concentrations osteoprotegerin failed inhibit approximately 40% OC formation, suggesting IL-7 acts via RANKL-dependent RANKL-independent pathways. Despite identification T-cell-secreted cytokine was not essential either or -independent secrete other capable substituting M-CSF action. On basis our data, we propose novel mechanism bone loss which induction from IL-1 TNFalpha leads cells. Thus, causes resorption involves activation T-cell-dependent augmentation osteoclastogenesis. (Blood. 2000;96:1873-1878)

参考文章(28)
R J Armitage, H M Sassenfeld, K H Grabstein, A E Namen, Regulation of human T cell proliferation by IL-7. Journal of Immunology. ,vol. 144, pp. 938- 941 ,(1990)
David Lane, Ed Harlow, Antibodies: A Laboratory Manual ,(1988)
Dirk M. Anderson, Eugene Maraskovsky, William L. Billingsley, William C. Dougall, Mark E. Tometsko, Eileen R. Roux, Mark C. Teepe, Robert F. DuBose, David Cosman, Laurent Galibert, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature. ,vol. 390, pp. 175- 179 ,(1997) , 10.1038/36593
Young-Yun Kong, Ulrich Feige, Iidiko Sarosi, Brad Bolon, Anna Tafuri, Sean Morony, Casey Capparelli, Ji Li, Robin Elliott, Susan McCabe, Thomas Wong, Giuseppe Campagnuolo, Erika Moran, Earl R. Bogoch, Gwyneth Van, Linh T. Nguyen, Pamela S. Ohashi, David L. Lacey, Eleanor Fish, William J. Boyle, Josef M. Penninger, Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature. ,vol. 402, pp. 304- 309 ,(1999) , 10.1038/46303
Y. Hara, T. Ukai, A. Yoshimura, H. Shiku, I. Kato, Histopathological Study of the Role of CD4- and CD8-Positive T Cells on Bone Resorption Induced by Escherichia coli Endotoxin Calcified Tissue International. ,vol. 63, pp. 63- 66 ,(1998) , 10.1007/S002239900490
Seishi Harada, Masahiro Yamamura, Hideyuki Okamoto, Yoshitaka Morita, Masanori Kawashima, Tetsushi Aita, Hirofumi Makino, Production of interleukin‐7 and interleukin‐15 by fibroblast‐like synoviocytes from patients with rheumatoid arthritis Arthritis & Rheumatism. ,vol. 42, pp. 1508- 1516 ,(1999) , 10.1002/1529-0131(199907)42:7<1508::AID-ANR26>3.0.CO;2-L
E Jimi, I Nakamura, H Amano, Y Taguchi, T Tsurukai, M Tamura, N Takahashi, T Suda, Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact Endocrinology. ,vol. 137, pp. 2187- 2190 ,(1996) , 10.1210/ENDO.137.8.8754795